Multiple myeloma presentation at ASH 2023

STATinMED to present at The Liver Meeting

An abstract co-authored by STATinMED was accepted for presentation at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting, in Boston, MA, Nov 10-14, 2023. STATinMED will attend and present the following: Prevalence of hepatitis B and D...
Multiple myeloma presentation at ASH 2023

ACG Accepts STATinMED Abstract

An abstract co-authored by STATinMED was accepted for presentation at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Vancouver, CA, Oct 20-25, 2023. Presentation time: Tues, Oct 24, 2023, 10:30AM – 4PM Burden of liver cancer among...
Multiple myeloma presentation at ASH 2023

ESPE Accepts Rare Disease Abstract

An abstract co-authored by STATinMED was accepted for presentation at the European Society for Paediatric Endocrinology (ESPE) in Hague, Netherlands, held Sept 21-23, 2023 Dose-dependent risks of glucocorticoid treatment in classic congenital adrenal hyperplasia Click...